Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals

Diabetologia

Volumn 59, Issue 5, 2016, Pages 980-988

  Carstensen, Bendix ^a   Read, Stephanie H ^b   Friis, Søren ^c   Sund, Reijo ^d   Keskimäki, Ilmo ^e   Svensson, Ann Marie ^f   Ljung, Rickard ^g   Wild, Sarah H ^b   Kerssens, Joannes J ^h   Harding, Jessica L ⁱ   Magliano, Dianna J ⁱ   Gudbjörnsdottir, Soffia ^f  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g KAROLINSKA INSTITUTE   (Sweden)

^h INFORMATION SERVICES DIVISION   (United Kingdom)

ⁱ BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cancer incidence; Cancer rate ratio; Cancer subtypes; Diabetes duration

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COLON CANCER; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE DURATION; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER; AUSTRALIA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FINLAND; INCIDENCE; NEOPLASMS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SCOTLAND; SWEDEN;

AUSTRALIA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; HUMANS; INCIDENCE; MALE; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SCOTLAND; SWEDEN;

EID: 84962925971     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-3884-9     Document Type: Article

References (36)

1. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16:1103–1123
2. Bonovas S, Filioussi K, Tsantes A (2004) Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 47:1071–1078
3. Weiderpass E, Ye W, Vainio H, Kaaks R, Adami HO (2002) Reduced risk of prostate cancer among patients with diabetes mellitus. Int J Cancer 102:258–261
4. Fall K, Garmo H, Gudbjornsdottir S, Stattin P, Zethelius B (2013) Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden. Cancer Epidemiol Biomark Prev: Publ Am Assoc Cancer Res, cosponsored by the Am Soc Prev Oncol 22:1102–1109
5. Pierce BL (2012) Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence. Urol Oncol 30:735–743
6. Smith U, Gale EAM (2009) Does diabetes therapy influence the risk of cancer? Diabetologia 52:1699–1708
7. Carstensen B, Witte DR, Friis S (2012) Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia 55:948–958
8. Yang X, Ko GTC, So WY et al (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes 59:1254–1260
9. Wild SH (2011) Diabetes, treatments for diabetes and their effect on cancer incidence and mortality: attempts to disentangle the web of associations. Diabetologia 54:1589–1592
10. Harding JL, Shaw JE, Peeters A, Cartensen B, Magliano DJ (2015) Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 38:264–270
11. Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K (2010) Cancer risk among patients hospitalized for type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med: J Br Diabet Assoc 27:791–797
12. Swerdlow AJ, Laing SP, Qiao Z et al (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92:2070–2075
13. Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, Ye W (2003) Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 95:1797–1800
14. Gordon-Dseagu VL, Shelton N, Mindell JS (2013) Epidemiological evidence of a relationship between type-1 diabetes mellitus and cancer: a review of the existing literature. Int J Cancer 132:501–508
15. Carstensen B (2007) Age-period-cohort models for the Lexis diagram. Stat Med 26:3018–3045
16. Harrell JFE (2006) Regression modeling strategies. Springer, New York
17. R Core Team (2014) R: a language and environment for statistical computing, Vienna, Austria
18. Carstensen B, Plummer M, Laara E, Hills M (2014) Epi: a package for statistical analysis in epidemiology. R package version 1.1.67. Available from http://CRAN.R-project.org/package=Epi, accessed 16 December 2015
19. Wideroff L, Gridley G, Mellemkjaer L et al (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360–1365
20. Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JPA (2015) Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350:g7607
21. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578
22. Scottish Diabetes Survey Monitoring Group (2014) Scottish Diabetes Survey 2014. NHS Scotland. Available from www.diabetesinscotland.org.uk/Publications.aspx?catId=3, accessed 19 January 2016
23. Swedish National Diabetes Register (2013) Annual report. Centre of Registers, Region Västra Götaland. In: www.ndr.nu/pdfs/Annual_Report_NDR_2013.pdf, accessed 19 January 2016
24. Karlstad O, Starup-Linde J, Vestergaard P et al (2013) Use of insulin and insulin analogs and risk of cancer—systematic review and meta-analysis of observational studies. Curr Drug Saf 8:333–348
25. Tang X, Yang L, He Z, Liu J (2012) Insulin glargine and cancer risk in patients with diabetes: a meta-analysis. PLoS One 7:e51814
26. 1c, independent of diabetes? Br J Cancer 110:2361–2368
27. Liao W-C, Tu Y-K, Wu M-S, Lin J-T, Wang H-P, Chien K-L (2015) Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ:g7371
28. Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862
29. Stevens RJ, Roddam AW, Beral V (2007) Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer 96:507–509
30. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013:965212
31. Vigneri R, Malandrino P, Vigneri P (2015) The changing epidemiology of thyroid cancer: why is incidence increasing? Curr Opin Oncol 27:1–7
32. Tsilidis KK, Allen NE, Appleby PN et al (2015) Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 136:372–381
33. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ (1996) Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88:1118–1126
34. Barrett-Connor E, Khaw KT, Yen SS (1990) Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 132:895–901
35. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076–2083
36. Frese T, Sandholzer H (2013) The epidemiology of type 1 diabetes mellitus. In: Escher AP, Li A (eds) Type 1 diabetes. InTech, Rijeka, Croatia